February 28, 2015

Biotechnology, Food & Drug Administration FDA News

Syndicate content

The National Law Review includes articles impacting the biotech and cleantech fields addressing: licensing and patent issues, intellectual property due diligence, litigation and tax. Content is also included addressing: greenhouse gas (GHG) regulation; mandated emissions reduction legislation; NEPA and CEQA claims, common law nuisance litigation; acquiring and selling emission offset and emission reduction credits and acid rain allowances under the United States Clean Air Act, SCAQMD RECLAIM and other air credit programs.

Date Title Organization
27
Feb
Grants Available for Specialty Crops – March 26 Deadline Varnum LLP
27
Feb
FDA Proposal to Regulate Laboratory Developed Tests Raises Legal Liability Questions for Labs Covington & Burling LLP
27
Feb
FTC to Accelerate Oncology Drug Growth, Requires Novartis to Divest Two Protein Inhibitors in Its Clinical Development Pipeline Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
25
Feb
The Court’s Decision in the FLANAX US Trademark Dispute Gives Bayer a Headache Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
24
Feb
Pharmaceutical Uses Acquisition to Make Itself More Competitive McBrayer, McGinnis, Leslie and Kirkland, PLLC
24
Feb
Early Signs of Continued Focus on Food Information, Authenticity and Traceability? Squire Patton Boggs (US) LLP
24
Feb
CMS Takes a Measured Approach to Medicare Advantage and Part D Plan Payment Rates and Policy Changes for 2016: Increased Part D Drug Costs Set the Stage for Higher Beneficiary Premiums Epstein Becker & Green, P.C.
23
Feb
FDA Issues Final Guidance Documents on Medical Device Data Systems and Medical Mobile Apps Barnes & Thornburg LLP
20
Feb
Deja Vu All Over Again: Federal GMO Labeling Legislation Re-Introduced Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
19
Feb
Go For De Novo: FDA’s Revised Approach to Medical Device Accessories Sheppard, Mullin, Richter & Hampton LLP
19
Feb
Life Sciences: Protecting the Crown Jewels Sills Cummis & Gross P.C.
18
Feb
M&A, Investment or Partnering Checklist for Medtech Companies Greenberg Traurig, LLP
18
Feb
FDA Issues Guidance for Mobile Medical Applications: What Will be Subject to FDA Oversight and Enforcement? Sheppard, Mullin, Richter & Hampton LLP
18
Feb
Medicare Fraud Plea in Detroit Pill Mill Case Mahany Law
18
Feb
Device Manufacturer Settles False Claims Act Allegations with DOJ for $1.25 Million Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
18
Feb
Growing Issues In A Miniature World: Nanomaterial Registers In The EU Squire Patton Boggs (US) LLP
16
Feb
Revised Seed Law Expected to Come into Effect Soon in China Michael Best & Friedrich LLP
13
Feb
DEA Rules On Disposal of Controlled Substances - What's Up? Poyner Spruill LLP
12
Feb
Prescribing and Telemedicine: The “Physical” Exam Epstein Becker & Green, P.C.
12
Feb
Interface without Regulation – FDA Deregulates MDDS and Related Technologies Sheppard, Mullin, Richter & Hampton LLP

Advertisement

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events

Thursday, March 5, 2015
Tuesday, April 14, 2015
Tuesday, April 14, 2015